Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Che C Colpitts

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Virology|January 4, 2013
5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped virusesChe C Colpitts, Alexey V Ustinov, Raquel F Epand, et al.
Plant Molecular Biology|October 31, 2009
Genome-wide analysis of the chalcone synthase superfamily genes of Physcomitrella patensP K Harshavardhan Koduri, Graeme S Gordon, Elizabeth I Barker, et al.
Journal of Virology|April 25, 2024
Virion-incorporated CD14 enables HIV-1 to bind LPS and initiate TLR4 signaling in immune cellsArvin T Persaud, Jasmin Khela, Claire Fernandes, et al.
The Journal of Infectious Diseases|February 16, 2020
Erratum to: Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis CAnne Olbrich, Hedda Wardemann, Stephan Böhm, et al.
The Journal of Infectious Diseases|June 6, 2019
Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis CAnne Olbrich, Hedda Wardemann, Stephan Böhm, et al.
Journal of Innate Immunity|January 17, 2025
RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm?Sophia K Stegeman, Olena Kourko, Heather Amsden, et al.
Elife|June 17, 2020
Hepatitis C virus exploits cyclophilin A to evade PKRChe C Colpitts, Sophie Ridewood, Bethany Schneiderman, et al.
Plos Pathogens|December 3, 2024
Cellular sialoglycans are differentially required for endosomal and cell-surface entry of SARS-CoV-2 in lung cell linesKimberley C Siwak, Emmanuelle V LeBlanc, Heidi M Scott, et al.
Gut|April 1, 2017
Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escapeChe C Colpitts, Rajiv G Tawar, Laurent Mailly, et al.
Hepatology (Baltimore, Md.)|August 13, 2011
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entrySandra Ciesek, Thomas von Hahn, Che C Colpitts, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Virology|January 4, 2013
5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped virusesChe C Colpitts, Alexey V Ustinov, Raquel F Epand, et al.
Plant Molecular Biology|October 31, 2009
Genome-wide analysis of the chalcone synthase superfamily genes of Physcomitrella patensP K Harshavardhan Koduri, Graeme S Gordon, Elizabeth I Barker, et al.
Journal of Virology|April 25, 2024
Virion-incorporated CD14 enables HIV-1 to bind LPS and initiate TLR4 signaling in immune cellsArvin T Persaud, Jasmin Khela, Claire Fernandes, et al.
The Journal of Infectious Diseases|February 16, 2020
Erratum to: Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis CAnne Olbrich, Hedda Wardemann, Stephan Böhm, et al.
The Journal of Infectious Diseases|June 6, 2019
Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis CAnne Olbrich, Hedda Wardemann, Stephan Böhm, et al.
Journal of Innate Immunity|January 17, 2025
RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm?Sophia K Stegeman, Olena Kourko, Heather Amsden, et al.
Elife|June 17, 2020
Hepatitis C virus exploits cyclophilin A to evade PKRChe C Colpitts, Sophie Ridewood, Bethany Schneiderman, et al.
Plos Pathogens|December 3, 2024
Cellular sialoglycans are differentially required for endosomal and cell-surface entry of SARS-CoV-2 in lung cell linesKimberley C Siwak, Emmanuelle V LeBlanc, Heidi M Scott, et al.
Gut|April 1, 2017
Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escapeChe C Colpitts, Rajiv G Tawar, Laurent Mailly, et al.
Hepatology (Baltimore, Md.)|August 13, 2011
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entrySandra Ciesek, Thomas von Hahn, Che C Colpitts, et al.
Pageof 6